$JNCE: Jounce Therapeutics Presents Reverse Translational, Biomarker …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675655/jounce-therapeutics-presents-reverse-translational-biomarker-and-precl

Related News:

$JNCE: Jounce Therapeutics, Inc. (JNCE) CEO Richard Murray on Q3 2018 …

$JNCE: Jounce Therapeutics to Present Two Posters from the JTX-2011 …

$JNCE: Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded …

$JNCE: Jounce Therapeutics to Present at the 2018 Cantor Global …

$JNCE: Jounce Therapeutics to Present Nonclinical Translational Data at …

$JNCE $SGMO $GILD $PFE: Biotech Fire Sale: 2 Top Stocks to Buy Next Week

Latest News:

$SPCB: SuperCom, Ltd. (SPCB) CEO Arie Trabelsi on Q3 2018 Results …

$NXTD: NXT-ID Inc. (NXTD) CEO Gino Pereira on Q3 2018 Results …

$LOW: Lowe’s Looks to Start Catching Up With Home Depot

$VIPS: Vipshop Holdings (VIPS) CEO Eric Shen on Q3 2018 Results …

$EA $AMZN $DIS $MSFT $TXN $XLNX: What We Learned from Microsoft, EA, TI and Booking’s Earnings Calls

$V $WYNN $TGT $OPK $BBBY $PANW: Visa, Wynn Resorts, Target: ‘Mad Money’ Lightning Round

$FIT: INVESTIGATION ALERT REMINDER: The Schall Law Firm …

$MNGA: MagneGas Corporation (MNGA) CEO Scott Mahoney on Q3 2018 …

$TGTX: Glancy Prongay & Murray LLP Announces the Filing of a Securities …

$SNDE: Sundance Energy Australia (SNDE) CEO Eric McCrady on Q3 2018 …

$FIT: Why Fitbit Is Down 1% So Far in 2018